Blockchain Registration Transaction Record

Clene Reports Q3 2024 Financial Results and Updates on CNM-Au8 Programs

Clene Inc. reports Q3 2024 financial results and updates on CNM-Au8 programs, demonstrating commitment to ALS treatment innovation. Visit www.Clene.com for more information. Investors can track CLNN updates at https://ibn.fm/CLNN.

Clene Reports Q3 2024 Financial Results and Updates on CNM-Au8 Programs

This news highlights Clene's advancements in ALS treatment innovation and financial progress, showcasing the company's commitment to neurodegenerative disease research. Investors can track CLNN updates at https://ibn.fm/CLNN.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x300aed31cadf58bc4e2384b23bb809c7c38154c82969e22d107c5f0295426cf9
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintnoonGmuI-90f3f0c8f6d80d71a0dc28e54f21d40b